Animal Growth Promoters and Performance Enhancers Market

The global animal antimicrobials and antibiotics market was majorly dominated by North America, followed closely by Europe in 2013. The Asian and RoW market will continue to grow at higher CAGR rates to drive the animal antimicrobials and antibiotics market. The market share of North America will decrease to 27%, primarily due to the regulatory bans posed on the use of antibiotics and dearth of new antibiotics in pharmaceutical companies pipelines. The rise of the Asian market will primarily be driven by rising demand for animal antimicrobials in China and India while RoW market growth will be dominated by growth in the Latin America region.

This can be mainly attributed to the increasing westernization, rise in the disposable incomes leading to high demand for animal protein products and pet animal ownership. The European market is also expected to grow at a similar pace as North America. Increasing animal protein products market coupled with animal related disease outbreaks and growing antibiotic resistance in the recent years has led to a strict regulatory environment for animal health products across the world, especially in the U.S. and the Europe.

The RoW market is poised to grow at a higher CAGR from 2013 to 2018 primarily due to growing demand for animal antimicrobials in the Latin American market. This is due to the increasing domestic meat demand, coupled with the region’s emergence as a key meat exporter and increased trend of companion animals ownership. Also, there has been an upsurge in the number of disease outbreaks in livestock in this region, making Latin America as one of the most lucrative market for animal antimicrobials in the global arena.

By 2018, injections segment will continue to drive and dominate the animal antimicrobials and antibiotics mode of delivery market, followed by oral powders and solutions market which is expected to grow at a CAGR of 4.8% during the forecast period.

Among animals segment, food-producing species accounted for the maximum share of 56.0% of the animal antimicrobials and antibiotics market in 2013. This segment is expected to grow at a CAGR of 4% to 6% during the forecast period of 2013 to 2018. China holds tremendous growth potential for the animal antimicrobials and antibiotics market during the forecast period of 2013 to 2018 and is expected to grow at a higher CAGR of 9.7% primarily driven by westernization of diets, increasing animal protein consumption, increased awareness towards health and safety of animals and rising trend of companion animal ownership.

Related Reports:

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018
https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]